NEW YORK(GenomeWeb) – Thermo Fisher Scientific said today that in collaboration with theUniversity of California, San Francisco and QB3, it has opened the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery at the Gladstone Institutes.
According to the company, the center will offer mass spectrometry technologies that will allow Gladstone Institute researchers to characterize protein dynamics in complex systems via approaches including creation of high-resolution protein-protein interaction maps; genome-directed proteomic screening and selection; and highly sensitive and quantitative analysis of protein expression and post-translational modifications.
The facility, to be directed by Gladstone senior investigator Nevan Krogan, will host instruments including Thermo Fisher's Orbitrap Fusion Tribrid and TSQ Quantiva Triple Quadrupole
"Gladstone, UCSF, QB3, and Dr. Krogan’s lab, including key members such as Jeffrey Johnson, have been doing exceptional work in the area of genetic and protein mapping in order to gain insight into disease pathways and mutations," Ken Miller, Thermo Fisher's vice president, research product marketing, said in a statement. "Through our collaboration, the new facility will enable researchers to apply state-of-the-art proteomics technologies to this critical area of research."
QB3 is a cooperative effort aimed at supporting science in California and helping commercialize research conducted at UCSF, UC Berkeley, and UC Santa Cruz. The Gladstone Institutes is an affiliate of UCSF conducting life science research.